Cancer Pain and Analgesia
Identifieur interne : 006F04 ( Main/Exploration ); précédent : 006F03; suivant : 006F05Cancer Pain and Analgesia
Auteurs : Paul J. Christo [États-Unis] ; Danesh Mazloomdoost [États-Unis]Source :
- Annals of the New York Academy of Sciences [ 0077-8923 ] ; 2008-09.
Abstract
Pain ranges in prevalence from 14–100% among cancer patients and occurs in 50–70% of those in active treatment. Cancer pain may result from direct invasion of tumor into nerves, bones, soft tissue, ligaments, and fascia, and may induce visceral pain through distension and obstruction. Cancer pain is multifaceted. Clinicians may describe cancer pain as acute, chronic, nociceptive (somatic), visceral, or neuropathic. Despite implementation of the WHO guidelines, reports of undertreatment of cancer pain persist in various clinical settings and in spite of decades of work to reduce unnecessary discomfort. Substantial obstacles to adequate pain relief with opioids include specific concerns of patients themselves, their family members, physicians, nurses, and the healthcare system. The WHO analgesic ladder serves as the mainstay of treatment for the relief of cancer pain in concert with tumoricidal, surgical, interventional, radiotherapeutic, psychological, and rehabilitative modalities. This multidimensional approach offers the greatest potential for maximizing analgesia and minimizing adverse effects. Primary therapies are directed at the source of the cancer pain and may enhance a patient's function, longevity, and comfort. Adjuvant therapies include nonopioids that confer analgesic effects in certain medical conditions but primarily treat conditions that do not involve pain. Nonopioid medications (over‐the‐counter agents) are useful in the management of mild to moderate pain, and their continuation through step 3 of the WHO ladder is an option after weighing a drug's risks and benefits in individual patients. Symptomatic treatment of severe cancer pain should begin with an opioid, regardless of the mechanism of the pain. They are very effective analgesics, titrate easily, and offer a favorable risk/benefit ratio. Cancer pain remains inadequately controlled despite the diagnostic and therapeutic means of ensuring that patients feel comfortable during their illness. Therefore, all practitioners need to make control of cancer pain a professional duty, even if they can only use the most basic and least expensive analgesic medications, such as morphine, codeine, and acetaminophen, to reduce human suffering.
Url:
DOI: 10.1196/annals.1414.033
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 002602
- to stream Istex, to step Curation: 002602
- to stream Istex, to step Checkpoint: 001163
- to stream Main, to step Merge: 007013
- to stream Main, to step Curation: 006F04
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Cancer Pain and Analgesia</title><author><name sortKey="Christo, Paul J" sort="Christo, Paul J" uniqKey="Christo P" first="Paul J." last="Christo">Paul J. Christo</name></author><author><name sortKey="Mazloomdoost, Danesh" sort="Mazloomdoost, Danesh" uniqKey="Mazloomdoost D" first="Danesh" last="Mazloomdoost">Danesh Mazloomdoost</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:527BA0523BD8BD05A586FC975C56F81038F6B6CD</idno><date when="2008" year="2008">2008</date><idno type="doi">10.1196/annals.1414.033</idno><idno type="url">https://api.istex.fr/document/527BA0523BD8BD05A586FC975C56F81038F6B6CD/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">002602</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002602</idno><idno type="wicri:Area/Istex/Curation">002602</idno><idno type="wicri:Area/Istex/Checkpoint">001163</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001163</idno><idno type="wicri:doubleKey">0077-8923:2008:Christo P:cancer:pain:and</idno><idno type="wicri:Area/Main/Merge">007013</idno><idno type="wicri:Area/Main/Curation">006F04</idno><idno type="wicri:Area/Main/Exploration">006F04</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Cancer Pain and Analgesia</title><author><name sortKey="Christo, Paul J" sort="Christo, Paul J" uniqKey="Christo P" first="Paul J." last="Christo">Paul J. Christo</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Anesthesiology & Critical Care Medicine, Division of Pain Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland</wicri:regionArea><placeName><region type="state">Maryland</region></placeName></affiliation></author><author><name sortKey="Mazloomdoost, Danesh" sort="Mazloomdoost, Danesh" uniqKey="Mazloomdoost D" first="Danesh" last="Mazloomdoost">Danesh Mazloomdoost</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Anesthesiology & Critical Care Medicine, Division of Pain Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland</wicri:regionArea><placeName><region type="state">Maryland</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Annals of the New York Academy of Sciences</title><title level="j" type="alt">ANNALS OF NEW YORK ACADEMY SCIENCES</title><idno type="ISSN">0077-8923</idno><idno type="eISSN">1749-6632</idno><imprint><biblScope unit="vol">1138</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="278">278</biblScope><biblScope unit="page" to="298">298</biblScope><biblScope unit="page-count">21</biblScope><publisher>Blackwell Publishing Inc</publisher><pubPlace>Malden, USA</pubPlace><date type="published" when="2008-09">2008-09</date></imprint><idno type="ISSN">0077-8923</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0077-8923</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Pain ranges in prevalence from 14–100% among cancer patients and occurs in 50–70% of those in active treatment. Cancer pain may result from direct invasion of tumor into nerves, bones, soft tissue, ligaments, and fascia, and may induce visceral pain through distension and obstruction. Cancer pain is multifaceted. Clinicians may describe cancer pain as acute, chronic, nociceptive (somatic), visceral, or neuropathic. Despite implementation of the WHO guidelines, reports of undertreatment of cancer pain persist in various clinical settings and in spite of decades of work to reduce unnecessary discomfort. Substantial obstacles to adequate pain relief with opioids include specific concerns of patients themselves, their family members, physicians, nurses, and the healthcare system. The WHO analgesic ladder serves as the mainstay of treatment for the relief of cancer pain in concert with tumoricidal, surgical, interventional, radiotherapeutic, psychological, and rehabilitative modalities. This multidimensional approach offers the greatest potential for maximizing analgesia and minimizing adverse effects. Primary therapies are directed at the source of the cancer pain and may enhance a patient's function, longevity, and comfort. Adjuvant therapies include nonopioids that confer analgesic effects in certain medical conditions but primarily treat conditions that do not involve pain. Nonopioid medications (over‐the‐counter agents) are useful in the management of mild to moderate pain, and their continuation through step 3 of the WHO ladder is an option after weighing a drug's risks and benefits in individual patients. Symptomatic treatment of severe cancer pain should begin with an opioid, regardless of the mechanism of the pain. They are very effective analgesics, titrate easily, and offer a favorable risk/benefit ratio. Cancer pain remains inadequately controlled despite the diagnostic and therapeutic means of ensuring that patients feel comfortable during their illness. Therefore, all practitioners need to make control of cancer pain a professional duty, even if they can only use the most basic and least expensive analgesic medications, such as morphine, codeine, and acetaminophen, to reduce human suffering.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Maryland</li></region></list><tree><country name="États-Unis"><region name="Maryland"><name sortKey="Christo, Paul J" sort="Christo, Paul J" uniqKey="Christo P" first="Paul J." last="Christo">Paul J. Christo</name></region><name sortKey="Mazloomdoost, Danesh" sort="Mazloomdoost, Danesh" uniqKey="Mazloomdoost D" first="Danesh" last="Mazloomdoost">Danesh Mazloomdoost</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006F04 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 006F04 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:527BA0523BD8BD05A586FC975C56F81038F6B6CD
|texte= Cancer Pain and Analgesia
}}
| This area was generated with Dilib version V0.6.31. |  |